Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Jump to: Headline numbers | How retatrutide and Wegovy work | Why retatrutide produces more weight loss | Side effects compared | Cardiovascular and long-term safety | Muscle and lean mass | Drug interactions and contraception | Mental health | UK access today vs the realistic timeline | Switching considerations | Who should consider which | FAQs | Take home message | Second Natures Mounjaro programme | References In Phase 3 human trials, retatrutide leads to more average weight loss than Wegovy
No peer-reviewed clinical trial data confirm a direct pharmacological link between retatrutide and changes in libido or sexual function
3.7 out of 5 from GLP-1.Reviews, reflecting its strong market position and broad medication menu alongside real concerns about customer service and BBB standing
A clinical trial found that in patients with MCI, a 32-week trial of slow-release exenatide had no beneficial effect on cognitive performance (Dei Cas et al., 2024)
US$ 22.88
US$ 23.10
US$ 26.03
US$ 21.78
US$ 29.50
